Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank67
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P67
Within normal range
Average
-212.72%
Historical baseline
PeriodValueYoY Change
20240.00%-
20230.00%+100.0%
2022-395.40%+13.2%
2021-455.46%-